Search Results | Chinese Journal of Pharmacoepidemiology

Home Results

A total of 6 result was found. Results that relate to Markov model

沙库巴曲缬沙坦、达格列净和恩格列净治疗射血分数降低心力衰竭的成本-效用分析

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

DOI：10.19960/j.issn.1005-0698.202308006

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details Download Mobile
阿贝西利联合氟维司群二线治疗HR+/HER2-晚期乳腺癌的成本-效果分析

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

DOI：10.19960/j.issn.1005-0698.202311009

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details Download Mobile
阿扎胞苷与地西他滨治疗骨髓增生异常综合征的成本-效用分析

La-Ji DANZENG Yong-Gong YANG Si-Liang WANG Meng-Ying LIU

DOI：10.19960/j.issn.1005-0698.202312007

Azacitidine Decitabine Myelodysplastic syndrome Markov model Cost-utility analysis Pharmacoeconomics
Details Download Mobile
恩扎卢胺治疗转移性前列腺癌的成本-效果分析

YANG Lei WANG Fengling HUANG Ling LI Yan ZHENG Hanrui ZHENG Lingli CHEN Li

DOI：10.12173/j.issn.1005-0698.202304008

Enzalutamide Metastatic prostate cancer Markov model Cost-effectiveness analysis
Details Download Mobile
基于Markov模型的胰高血糖素样肽1受体激动剂联合二甲双胍治疗２型糖尿病药物经济学评价

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

DOI：10.12173/j.issn.1005-0698.202304014

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details Download Mobile
氟替美维吸入粉雾剂治疗慢性阻塞性肺疾病的药物经济学评价

DING Xueru LIU Huimin HE Xiaodong LI Hua LI Zhihao

DOI：10.12173/j.issn.1005-0698.202404016

Fluticasone furoate/umeclidinium/vilanterol Chronic obstructive pulmonary disease Markov model Cost-utility analysis Pharmacoeconomic
Details Download Mobile